Based
ARLINGTON, MASSACHUSETTS
ARLINGTON, MASSACHUSETTS
Industry group
Pharmaceuticals
Pharmaceuticals
Filings
4
4
Raised (new offerings)
$4M
$4M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-03-17 | New offering first sale 2026-03-03 | $1.75M | $1.75M | SEC filing |
| 2026-02-13 | New offering first sale 2026-01-30 | $2.25M | $4.20M | SEC filing |
| 2024-12-31 | Filing | — | — | SEC filing |
| 2024-06-28 | Filing | — | — | SEC filing |
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from KALA BIO, Inc.'s own filings with the SEC. The people those filings name are on the team page.